Value of percutaneous transhepatic cholangiography in "institutional jaundice".
D000230:Adenocarcinoma / Q000150:complications / Q000473:pathology; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002740:Chlorothiazide / Q000009:adverse effects / Q000627:therapeutic use; D002758:Cholangiography; D002769:Cholelithiasis / Q000150:complications / Q000473:pathology; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D007565:Jaundice / Q000139:chemically induced / Q000000981:diagnostic imaging* / Q000209:etiology / Q000473:pathology; D008099:Liver / Q000000981:diagnostic imaging* / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000150:complications / Q000473:pathology; D010640:Phenothiazines
D014150:Antipsychotic Agents; D010640:Phenothiazines; D002740:Chlorothiazide